Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma

NCT01090089 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide, Dexamethasone
DRUG: Lenalidomide, Dexamethasone, PBSCT

Sponsor

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Collaborators

[object Object]